Manasi Agrawal
Appearances
- DateMay 8, 2023Aconitate decarboxylase 1 (ACOD1; also known as IRG-1) is the ubiquitous source of the metabolite itaconate, which dampens inflammasome activation by preventing HIF1α production of IL-1β and prevents TNF production through NRF2 activation…
Presenter
Speakers
Icahn School of Medicine at Mount SinaiIcahn School of Medicine at Mount Sinai - DateMay 6, 2023BACKGROUND: Prevention of postoperative recurrence (POR) in Crohn’s disease (CD) after ileo-colonic (IC) resection is still a highly debated topic. Prophylactic immunosuppression after surgery is currently recommended in presence of at least one clinical risk factor (RF)…
Presenter
Speakers
NYU Langone HealthIcahn School of Medicine at Mount Sinai - DateMay 18, 2024Approximately 20-30% of individuals with Crohn's disease (CD) experience a relatively mild disease course without progression. However, there is no widely accepted objective definition of mild CD. We aimed to identify endoscopic severity cut-offs that can be used to define mild non-progressive CD…
Presenter
Speakers
Icahn School of Medicine at Mount SinaiMassachusetts General Hospital - DateMay 21, 2024Specific pollutants and environmental exposures are implicated in modulating inflammatory bowel disease (IBD) risk. Crohn’s disease (CD) clustering has been reported in agricultural areas…
Speakers
Icahn School of Medicine at Mount SinaiPresenter
- DateMay 21, 2024The strongest independent risk factor for developing inflammatory bowel disease (IBD) is a family history with IBD. The early life, including the intra-uterine period, is critical for immune system maturation and therefore, exposures during early life can influence IBD risk…